Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
21 Jan 2017 | 7:08 PM
 

Biocon Ltd. Share Price Live (BSE)
0

BSE Code: 532523 | NSE Symbol: BIOCON
973.50
-20.75
(-2.08 %)
20 Jan 2017 | 04:01 PM
Change company
  • Open (Rs)
    980.00
  • Prev. close (Rs.)
    994.25
  • High (Rs.)
    998.55
  • Low (Rs.)
    971.00
  • 52W H (Rs.)
    1,052.05
  • 52W L (Rs.)
    430.80
  • Volume (Rs.)
    115423
  • MCap (Rs in Cr.)
    19,470.00
999.7
3.05
(0.31 %)
  • Open (Rs)
    993.90
  • High (Rs)
    1,000.70
  • Low (Rs)
    993.85
  • Prev. close(Rs)
    996.65
  • Contracts Tra.
    48,000
  • Turnover (Cr.)
    5
  • Open Interest
    28,42,200
  • Open Int. chg
    -25,06,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
44.81
Operating Margin (%)
23.52
Gross Profit Margin (%)
16.57
Net Profit Margin (%)
25.71
Total Debt/Equity
0.61
Dividend payout Ratio (Net Profit)
12.81
Earning Retention Ratio
70.95

News

12 Jan 2017 - 09:59:00-Shares of Biocon an Indian biopharmaceutical company rose over 5 per cent hitting 52-week high in ea...
12 Jan 2017 - 09:29:00-Biocon Ltd. has said that the U.S...
09 Nov 2016 - 09:31:00-Biocon Ltd...
04 Nov 2016 - 09:40:00-Biocon Ltd...

Announcements

18-Jan-2017
Biocon - Shareholding for the Period Ended December 31 2016
11-Jan-2017
Biocon - U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon`s Proposed Biosimilar Trastuzumab
07-Jan-2017
Biocon - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended December 31 201
27-Dec-2016
Biocon - Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon`s Proposed Biosimilar Trastuzumab Phas
27-Dec-2016
Biocon - Q3 results on Jan 24 2017

Religare Research

20 Jan 2017 | 06:00 PM
PTC India Financial Services (PFS) is a non-banking finance company promoted by PTC India (60% stake...
20 Jan 2017 | 06:00 PM
Nifty index traded sideways for most past of the passing week but steep sell-off on Friday i.e. 20th...
20 Jan 2017 | 03:33 PM
The Union Budget is round the corner, and before we try to gaze at what it might have in store, ther...
20 Jan 2017 | 10:23 AM
Agri Technical report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,50,000 46.60 22.58 1.22
10,50,000 46.60 39.39 1.22
10,50,000 46.60 40.54 1.22
10,50,000 46.60 25.80 1.22
0 42.76 23.57 0.65

Shareholding Pattern

       
Promotors60.68%
Mutual Funds/UTI2.83%
FI/Banks1.63%
Insurance1.63%
FII16.96%
Government0.00%
Others4.13%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,936.00(-0.12)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,752.10(0.07)
3317
 Ajanta Pharma Ltd.
1,780.00(0.39)
3790
 Piramal Enterprises Ltd.
1,764.00(-3.81)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Biocon Ltd.10.05-6.75272.00
NIFTY(S&P CNX)266.95-350.05-160.75
BSE SENSEX726.52-1,095.34-881.39
BSE 500465.82-538.8935.24

Corporate Details

Key Personal
Arun Chandavarkar
Joint Managing Director & CEO
Bala S Manian
Non Exe. & Ind. Director
Charles L Cooney
Non Exe. & Ind. Director
Key Address
Registered Office
20th K.M. Hosur Road Hebbagodi Electronics City,Bengaluru,Karnataka

Tel:080-28082808 28082037, Fax:080-28523423

investor.relations@biocon.com
http://www.biocon.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Biocon Ltd. that will help you decide whether to buy, sell or hold Biocon Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Biocon Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.